NSETrading Window29 Sept 2026 · 29 Sept 2026, 01:02 pm

Trading Window

Fermenta Biotech Limited · FERMENTA

✦ AI Summary

Fermenta Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fermenta Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

FERMENTABIOTECH_29092026130236_ClosureofTWintimation30092026.pdf

pdf

Download →
View document text
September 29, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, Dalal Street, Fort, G Block, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai 400 051 Scrip Code: 506414 Trading Symbol: FERMENTA Dear Sirs, Sub: Notice of the Closure of Trading Window Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, Company's Code of Conduct for Prevention of Insider Trading and BSE circular no. LIST/COMP/01/2019-20 dated April 2, 2019 regarding intimation for closure of Trading Window, it is hereby notified that the “Trading Window” i.e. period for trading in Company’s securities, will be closed with effect from October 01, 2026 till 48 hours after the announcement of unaudited financial results of the Company for the quarter and half year ending on September 30, 2026, as may be approved at the concerned Board Meeting. The intimation regarding the Board Meeting date will be announced in due course. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company’s equity shares, either in their own name or in the name of their immediate relatives. Terms not defined in this notice shall have the same meaning as defined in the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders. Note: Please note that pursuant to BSE Limited circular no. LIST/COMP/01/2019-20 dated April 2, 2019, titled “Clarification regarding trading restriction period”, the trading window shall close from the end of every quarter i.e. March 31, June 30, September 30 and December 31 and shall open only after 48 hours of declaration of financial results for every quarter approved at the concerned Board Meeting. The date(s) of Board Meeting(s) for considering the respective financial results shall be intimated as and when decided. Yours faithfully, For Fermenta Biotech Limited Varadvinayak Khambete Company Secretary & Head – Legal Membership No. A33861